Department of Medicine; Diabetes Center of Excellence; Program in Bioinformatics and Integrative Biology; Graduate School of Biomedical Sciences
Endocrine System Diseases | Endocrinology, Diabetes, and Metabolism | Immune System Diseases | Immunology and Infectious Disease | Nutritional and Metabolic Diseases
Type 1 diabetes is a chronic autoimmune disease, characterized by the immune-mediated destruction of insulin-producing beta cells of pancreatic islets. Essential components of the innate immune antiviral response, including type I IFN and IFN receptor (IFNAR)-mediated signaling pathways, likely contribute to human type 1 diabetes susceptibility. We previously showed that LEW.1WR1 Ifnar1 (-/-) rats have a significant reduction in diabetes frequency following Kilham rat virus (KRV) infection. To delineate the impact of IFNAR loss on immune cell populations in KRV-induced diabetes, we performed flow cytometric analysis in spleens from LEW.1WR1 wild-type (WT) and Ifnar1 (-/-) rats after viral infection but before the onset of insulitis and diabetes. We found a relative decrease in CD8(+) T cells and NK cells in KRV-infected LEW.1WR1 Ifnar1 (-/-) rats compared with KRV-infected WT rats; splenic regulatory T cells were diminished in WT but not Ifnar1 (-/-) rats. In contrast, splenic neutrophils were increased in KRV-infected Ifnar1 (-/-) rats compared with KRV-infected WT rats. Transcriptional analysis of splenic cells from KRV-infected rats confirmed a reduction in IFN-stimulated genes in Ifnar1 (-/-) compared with WT rats and revealed an increase in transcripts related to neutrophil chemotaxis and MHC class II. Single-cell RNA sequencing confirmed that MHC class II transcripts are increased in monocytes and macrophages and that numerous types of splenic cells harbor KRV. Collectively, these findings identify dynamic shifts in innate and adaptive immune cells following IFNAR disruption in a rat model of autoimmune diabetes, providing insights toward the role of type I IFNs in autoimmunity.
diabetes, immunity, autoimmunity
Rights and Permissions
Copyright © 2021 The Authors. This article is distributed under the terms of the CC BY 4.0 Unported license.
DOI of Published Version
Qaisar N, Arowosegbe A, Derr AG, Kucukural A, Satish B, Racicot R, Guo Z, Trombly MI, Wang JP. Type I IFN-Driven Immune Cell Dysregulation in Rat Autoimmune Diabetes. Immunohorizons. 2021 Oct 26;5(10):855-869. doi: 10.4049/immunohorizons.2100088. PMID: 34702762. Link to article on publisher's site
Qaisar N, Arowosegbe A, Derr AG, Kucukural A, Satish B, Racicot R, Guo Z, Trombly MI, Wang JP. (2021). Type I IFN-Driven Immune Cell Dysregulation in Rat Autoimmune Diabetes. University of Massachusetts Medical School Faculty Publications. https://doi.org/10.4049/immunohorizons.2100088. Retrieved from https://escholarship.umassmed.edu/faculty_pubs/2129
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Endocrine System Diseases Commons, Endocrinology, Diabetes, and Metabolism Commons, Immune System Diseases Commons, Immunology and Infectious Disease Commons, Nutritional and Metabolic Diseases Commons